Chemical Structure (Terconazole 01)
Terconazole Cream
Product Images NDC 51672-1302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terconazole (NDC 51672-1302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Terconazole 02)
Figure 2 (Terconazole 03)
Figure 3 (Terconazole 04)
Figure 4 (Terconazole 05)
This appears to be a list of anatomical structures in the pelvic region of the body: the urinary opening, the vagina, and the rectum.*
Principal Display Panel (20 g Tube Carton)
This is a leaflet containing important patent information for a vaginal cream with terconazole 0.8%. It includes instructions for use, storage information, medication precautions, and a warning to keep it out of reach of children. The leaflet also mentions a combined insert for pharmacists and instructions for dispensing prescription medication. Additionally, there are some unreadable characters and a code at the end.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
